Dong Xin, M.D., Ph.D.

Position: Vice Chair of HPB Surgery

Department:HPB Surgery

Medical School:Zhejiang University School of Medicine, China

Academic Rank:Professor, Chief Physician

Appointment

Clinical / Research Interests

Minimally invasive treatment of hepatobiliary and pancreatic diseases

Hepatic cirrhosis and portal hypertension

Pancreatic disorders

Radiofrequency ablation for liver lesions

Professional Highlights

Advanced worker of Zhejiang University School of Medicine, 2016

Advanced worker of Zhejiang University, 2014

Professional Appointments

Vice Chair, Tumor Data Intelligent Physical Therapy Committee of Zhejiang Mathematical Medical Association, 2020-Present

Member, Committee for Minimally Invasive Treatment of Tumors of Shanghai Anti-Cancer Society, 2020-Present

Member, Tumor Ablation Committee of Zhejiang Anti-Cancer Society, 2019-Present


Education Experience

Research Summary

Prof. Dong is interested in locating tumor markers for hepatic, biliary, pancreatic and gastric cancer, early diagnosis of pancreatic carcinoma and immunotherapy for pancreatic and hepatic carcinoma.


Publications

Dong X*, Zhou YZ, Wang LT, Peng JF, Lou YB, Fan YQ. Liver Cancer Detection Using Hybridized Fully Convolutional Neural Network Based on Deep Learning Framework. IEEE Access. 2020:8:129889-129898.

Lou YB, Fan FX, Mu YC, Dong X*. The implication of diabetes metabolomics in the early diagnosis and pathogenesis of pancreatic cancer. J Biol Regul Homeost Agents. 2018; 32 (1):75-82.

Xin Dong, Yan Bo Lou, Yun Chuan Mu, Mu Xing Kang, Yu Lian Wu*. Predictive Factors for Differentiating Pancreatic Cancer Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreatic Cancer. Digestion. 2018: 98(4):209-216.

Huang H#, Dong X#, Kang MX, Xu B, Chen Y, Zhang B, Chen J, Xie QP, Wu YL*. Novel Blood Biomarkers of Pancreatic Cancer – Associated Diabetes Mellitus Identified by Peripheral Blood–Based Gene Expression Profiles. Am J Gastroenterol. 2010: 105(7):1661-9.

Muxing Kang, Xing Dong, Wenjie Lu, Yulian Wu*.Vanin-1 as a biomarker for pancreatic cancer associated new-onset diabetes has been proven in clinical and laboratory research. Pancreas. 2014: 43(8):1374.

Xin Dong, Yin Chu Zhan, Ren Ya Jiang, Qiu Ping Xie, Jia Ping Peng, Jing Wang, Shun Liang Gao, and Yu Lian Wu*. The Potential Effect of Proteasome Inhibitor PS-341 on Severe Acute Pancreatitis Detected by Positron Emission Tomography in ICR Mice. Journal of Surgical Research. 2010: 162, 193-202.

Dong X, Zhang B, Kang MX, Chen Y, Guo QQ, Wu YL*. Analysis of pancreatic fistula according to the International Study Group on Pancreatic Fistula classification scheme for 294 patients who underwent pancreaticoduodenectomy in a single center. Pancreas. 2011: 40(2):222-8.

Xin Dong, Shun Liang Gao, Qiu Ping Xie, Lin Xu, Yuan Liang Xu, and Yu Lian Wu*, In Situ High-Volume Modified Continuous Closed and/or Open Lavage for Infected Necrotizing Pancreatitis. Pancreas 2008;36:44-49.

Qingqu Guo, Muxin Kang, Bo Zhang, Ying Chen, Xin Dong, Yulian Wu*. Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes. J Cancer Res Clin Oncol. 2010: 136(11):1627-31.

Hai Huang, Xin Dong, Shun-Liang Gao, Yu-Lian Wu*. Conservative resection for benign tumors of the proximal pancreas. World J Gastroenterol 2009:28; 15(32): 4044-4048.


Current Program

Find People

Search by Family Name

Find A Department

Search by Departments